{"id":"https://openalex.org/W3199130624","doi":"https://doi.org/10.1212/wnl.94.15_supplement.5257","title":"Galcanezumab in the Prevention of Chronic Migraine in Patients on Botulinum Toxin Therapy (5257)","display_name":"Galcanezumab in the Prevention of Chronic Migraine in Patients on Botulinum Toxin Therapy (5257)","publication_year":2020,"publication_date":"2020-04-14","ids":{"openalex":"https://openalex.org/W3199130624","doi":"https://doi.org/10.1212/wnl.94.15_supplement.5257","mag":"3199130624"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.94.15_supplement.5257","doi":"https://doi.org/10.1212/wnl.94.15_supplement.5257","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1212/wnl.94.15_supplement.5257","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101611143","display_name":"Shivangi Singh","orcid":"https://orcid.org/0009-0006-3984-8107","observed_orcids":["https://orcid.org/0009-0006-3984-8107","https://orcid.org/0009-0000-1537-8020"]},"institutions":[{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shivangi Singh","raw_affiliation_strings":["University of Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Missouri","institution_ids":["https://openalex.org/I76835614"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Harsh Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harsh Singh","raw_affiliation_strings":["University of Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Missouri","institution_ids":["https://openalex.org/I76835614"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101865867","display_name":"Raghav Govindarajan","orcid":"https://orcid.org/0000-0003-0419-9072","observed_orcids":["https://orcid.org/0000-0003-0419-9072"]},"institutions":[{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raghav Govindarajan","raw_affiliation_strings":["University of Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Missouri","institution_ids":["https://openalex.org/I76835614"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I76835614"],"apc_list":null,"apc_paid":null,"fwci":0.5081,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.66115577,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"94","issue":"15_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10852","display_name":"Temporomandibular Joint Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3504","display_name":"Oral Surgery"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/galcanezumab","display_name":"galcanezumab","score":0.9769999980926514},{"id":"https://openalex.org/keywords/chronic-migraine","display_name":"chronic migraine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/botulinum-toxin-type-a","display_name":"botulinum toxin type A","score":0.8259999752044678},{"id":"https://openalex.org/keywords/migraine-prevention","display_name":"migraine prophylaxis","score":0.7950000166893005},{"id":"https://openalex.org/keywords/anti-cgrp-monoclonal-antibodies","display_name":"CGRP monoclonal antibodies","score":0.8980000019073486},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/monthly-headache-days","display_name":"monthly headache days","score":0.6439999938011169},{"id":"https://openalex.org/keywords/abortive-therapy","display_name":"abortive treatment","score":0.7680000066757202},{"id":"https://openalex.org/keywords/cgrp-receptor-antagonism","display_name":"CGRP receptor antagonism","score":0.6710000038146973},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.703000009059906},{"id":"https://openalex.org/keywords/headache-related-disability","display_name":"headache-related disability","score":0.46799999475479126},{"id":"https://openalex.org/keywords/migraine-disability","display_name":"migraine disability","score":0.40299999713897705},{"id":"https://openalex.org/keywords/migraine-related-impairment","display_name":"migraine-related impairment","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C2910587157","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Chronic Migraine","level":3,"score":0.8579566478729248},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7750582695007324},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.7503743171691895},{"id":"https://openalex.org/C2777478456","wikidata":"https://www.wikidata.org/wiki/Q208413","display_name":"Botulinum toxin","level":2,"score":0.7329369187355042},{"id":"https://openalex.org/C2777367657","wikidata":"https://www.wikidata.org/wiki/Q184651","display_name":"Toxin","level":2,"score":0.45762619376182556},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35395926237106323},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34349656105041504},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.17296519875526428},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.06393557786941528},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.048800885677337646}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.94.15_supplement.5257","doi":"https://doi.org/10.1212/wnl.94.15_supplement.5257","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1212/wnl.94.15_supplement.5257","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3161426658","https://openalex.org/W2979669228","https://openalex.org/W2901687990","https://openalex.org/W4403367536","https://openalex.org/W4386461770","https://openalex.org/W4389368593","https://openalex.org/W4319040147","https://openalex.org/W7154274668","https://openalex.org/W4389683923","https://openalex.org/W4389441206"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"Assess":[2],"the":[3,37,56,63,72,141,206,255,261,288],"Efficacy":[4],"of":[5,30,36,44,59,67,74,217,251,268,290],"Galcanezumab":[6,291],"in":[7,140,239,254,292],"Patients":[8,179],"with":[9,55,128,157,175,187,200,211,243,260,274,294,303],"Chronic":[10,16],"Migraine":[11],"Refractory":[12],"to":[13,100,134,155,276,310,316,322],"Botulinum":[14,135,147,176,201,275],"Background:":[15],"migraine":[17,38,107,165],"(CM),":[18],"defined":[19],"by":[20],"headache":[21,166],"occurring":[22],"at":[23,32,49,150],"least":[24,33,151],"15":[25],"days":[26,167,250],"per":[27],"month":[28,208],"and":[29,52,131,163,172,177,297],"which":[31],"8":[34],"are":[35,117],"type,":[39],"is":[40,47,103],"a":[41,237,298],"major":[42],"cause":[43],"morbidity.":[45],"Management":[46],"aimed":[48],"both":[50],"abortive":[51,161,252],"preventive":[53],"therapy":[54,148,162,253],"latter":[57],"being":[58],"paramount":[60],"importance":[61],"given":[62],"impact":[64],"on":[65,110,215],"quality":[66],"life.":[68],"Clinical":[69],"evidence":[70,286],"supports":[71],"use":[73,289],"botulinum":[75],"toxin":[76],"A":[77,137],"and,":[78],"more":[79],"recently,":[80],"anti-calcitonin":[81],"gene":[82],"related":[83],"peptide":[84],"(anti-CGRP)":[85],"antibodies":[86],"for":[87,105,114,149,160,182,202,287],"refractory":[88,133,295],"CMs.":[89],"Galcanezumab,":[90,212],"an":[91,266],"anti-CGRP":[92],"monoclonal":[93],"antibody":[94],"that":[95],"prevents":[96],"CGRP":[97],"from":[98],"binding":[99],"its":[101],"receptors,":[102],"approved":[104],"chronic":[106],"prophylaxis.":[108],"Data":[109],"combined":[111,302],"treatment":[112,132,156,174,186,199,210,229,242,259,273],"approaches":[113],"CMs,":[115],"however,":[116],"limited.":[118],"Design/Methods:":[119],"Ten":[120],"patients":[121,144,192,213,235,246,293],"(8":[122],"F,":[123],"29":[124],"\u00b1":[125,195,219,232,270,278],"5.5":[126],"yr)":[127],"documented":[129],"CM":[130],"Toxin":[136],"were":[138,169,180],"enrolled":[139],"study.":[142],"All":[143,234,245],"had":[145],"received":[146],"1":[152,203],"year":[153],"prior":[154],"Galcanezumab.":[158,178,188,244,281],"Need":[159],"monthly":[164],"(MHDs)":[168],"assessed":[170],"before":[171],"after":[173,185,198,209,228,241,272,280],"followed":[181],"3":[183,226,256],"months":[184,227,257],"Results:":[189],"On":[190],"average,":[191],"reported":[193,214,225],"16.4":[194],"1.2":[196],"MHDs":[197,224],"year.":[204],"In":[205],"first":[207],"average":[216,267],"15.9":[218],"1.0":[220],"MHDs.":[221],"The":[222],"mean":[223],"was":[230],"12.1":[231],"1.5.":[233],"saw":[236],"reduction":[238],"MHD":[240],"also":[247],"required":[248],"fewer":[249],"following":[258],"medication":[262],"\u2013":[263],"down":[264],"form":[265],"6.3":[269],"1.1":[271],"4.9":[277],"0.7":[279],"Conclusions:":[282],"This":[283],"study":[284],"provides":[285],"CMs":[296],"synergistic":[299],"effect":[300],"when":[301],"Botulinum.":[304],"Disclosure:":[305],"Dr.":[306,312,318],"Singh":[307,313],"has":[308,314,320],"nothing":[309,315,321],"disclose.":[311,317,323],"Govindarajan":[319]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2021-09-27T00:00:00"}